Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Gelineau Syndrome

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Gelineau Syndrome in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mori, T1
Uzawa, N1
Iwase, Y1
Masukawa, D1
Rahmadi, M1
Hirayama, S1
Hokazono, M1
Higashiyama, K1
Shioda, S1
Suzuki, T1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Gelineau Syndrome

ArticleYear
Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT.
    Psychopharmacology, 2016, Volume: 233, Issue:12

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dose-Response Relationship, Drug; Male; Mice; Mice,

2016